AR022213A1 - Compuestos ciclicos utiles como inhibidores de metaloproteinas, proceso para prepararlos; composiciones formuladas con dichos compuestos; proceso parapreparar dichas composiciones; uso de dichos compuestos - Google Patents
Compuestos ciclicos utiles como inhibidores de metaloproteinas, proceso para prepararlos; composiciones formuladas con dichos compuestos; proceso parapreparar dichas composiciones; uso de dichos compuestosInfo
- Publication number
- AR022213A1 AR022213A1 ARP000100043A ARP000100043A AR022213A1 AR 022213 A1 AR022213 A1 AR 022213A1 AR P000100043 A ARP000100043 A AR P000100043A AR P000100043 A ARP000100043 A AR P000100043A AR 022213 A1 AR022213 A1 AR 022213A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- compositions
- optionally substituted
- useful
- metaloprotein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
- C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Se trata de compuestos de la formula (1) en la cual R1 es alquilo inferior, halogeno, grupo heterocíclico opcionalmente sustituido o arilo opcionalmentesustituido; R2 es carboxi, carboxi protegido o carboxi amidado; Ar es arilo opcionalmentesustitui do o grupo heterocíclico opcionalmente sustituido; A esalquileno inferior; X es oxa o un enlace simple; Y es tia, sulfinil o sulfonil; Z es metileno, tia, sulfinil o sulfonil; m y n son, cada uno de ellos, unnumero entre 0 y 6, y 1 < o = m+ n < o = 6; y su sal. Dichos compuestos resultan de utilidad como inhibidor de metaloproteínas matrices (MMP) o del factor denecrosis tumoral alfa (TNF alfa). También se proponen los objetos restantes indicados en el título de la presente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP8068A AUPP806899A0 (en) | 1999-01-07 | 1999-01-07 | Cyclic compound |
AUPQ1702A AUPQ170299A0 (en) | 1999-07-19 | 1999-07-19 | Cyclic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
AR022213A1 true AR022213A1 (es) | 2002-09-04 |
Family
ID=25645967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000100043A AR022213A1 (es) | 1999-01-07 | 2000-01-06 | Compuestos ciclicos utiles como inhibidores de metaloproteinas, proceso para prepararlos; composiciones formuladas con dichos compuestos; proceso parapreparar dichas composiciones; uso de dichos compuestos |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1140895B1 (es) |
JP (1) | JP2002534424A (es) |
KR (1) | KR20010102968A (es) |
CN (1) | CN1343206A (es) |
AR (1) | AR022213A1 (es) |
AT (1) | ATE262517T1 (es) |
BR (1) | BR0008589A (es) |
CA (1) | CA2357874A1 (es) |
DE (1) | DE60009260T2 (es) |
ES (1) | ES2213563T3 (es) |
HK (1) | HK1045312A1 (es) |
HU (1) | HUP0104859A3 (es) |
MX (1) | MXPA01006896A (es) |
RU (1) | RU2221792C2 (es) |
TR (1) | TR200101936T2 (es) |
WO (1) | WO2000040576A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR755501A0 (en) * | 2001-09-07 | 2001-09-27 | Fujisawa Pharmaceutical Co., Ltd. | Cyclic compound |
JP2003081838A (ja) * | 2001-09-11 | 2003-03-19 | Rohto Pharmaceut Co Ltd | グルコサミン製剤 |
WO2003031431A1 (en) * | 2001-10-09 | 2003-04-17 | Bristol-Myers Squibb Company | Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
US8242139B2 (en) | 2007-04-30 | 2012-08-14 | Abbott Laboratories | Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme |
JPWO2009096198A1 (ja) * | 2008-02-01 | 2011-05-26 | 一般社団法人ファルマIp | 新規ビアリール誘導体 |
FR2962649A1 (fr) | 2010-07-19 | 2012-01-20 | Conservatoire Nat Arts Et Metiers | Traitement d'une pathologie liee a un effet excessif du tnf par un compose de benzene sulfonamide |
RU2536205C2 (ru) * | 2012-09-27 | 2014-12-20 | Федеральное Государственное Бюджетное Учреждение Науки Институт Нефтехимии И Катализа Ран | Способ получения 5-метоксикарбонил-1,3-дитиана, обладающего фунгицидной активностью |
WO2015028960A1 (en) * | 2013-08-28 | 2015-03-05 | Piramal Enterprises Limited | Substituted heterocyclic derivatives as gpr agonists and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8801300D0 (en) * | 1988-01-21 | 1988-02-17 | May & Baker Ltd | New compositions of matter |
-
2000
- 2000-01-06 AR ARP000100043A patent/AR022213A1/es unknown
- 2000-01-06 KR KR1020017008512A patent/KR20010102968A/ko not_active Application Discontinuation
- 2000-01-06 HU HU0104859A patent/HUP0104859A3/hu unknown
- 2000-01-06 ES ES00900122T patent/ES2213563T3/es not_active Expired - Lifetime
- 2000-01-06 AT AT00900122T patent/ATE262517T1/de not_active IP Right Cessation
- 2000-01-06 EP EP00900122A patent/EP1140895B1/en not_active Expired - Lifetime
- 2000-01-06 RU RU2001121981/04A patent/RU2221792C2/ru not_active IP Right Cessation
- 2000-01-06 MX MXPA01006896A patent/MXPA01006896A/es unknown
- 2000-01-06 JP JP2000592284A patent/JP2002534424A/ja not_active Withdrawn
- 2000-01-06 CA CA002357874A patent/CA2357874A1/en not_active Abandoned
- 2000-01-06 BR BR0008589-8A patent/BR0008589A/pt not_active IP Right Cessation
- 2000-01-06 TR TR2001/01936T patent/TR200101936T2/xx unknown
- 2000-01-06 CN CN00804771A patent/CN1343206A/zh active Pending
- 2000-01-06 DE DE60009260T patent/DE60009260T2/de not_active Expired - Fee Related
- 2000-01-06 WO PCT/JP2000/000018 patent/WO2000040576A2/en not_active Application Discontinuation
-
2002
- 2002-09-25 HK HK02106999.6A patent/HK1045312A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000040576A2 (en) | 2000-07-13 |
CN1343206A (zh) | 2002-04-03 |
RU2221792C2 (ru) | 2004-01-20 |
DE60009260T2 (de) | 2004-08-05 |
HUP0104859A2 (en) | 2002-10-28 |
EP1140895A2 (en) | 2001-10-10 |
ES2213563T3 (es) | 2004-09-01 |
HK1045312A1 (zh) | 2002-11-22 |
MXPA01006896A (es) | 2002-06-04 |
WO2000040576A3 (en) | 2001-03-22 |
JP2002534424A (ja) | 2002-10-15 |
CA2357874A1 (en) | 2000-07-13 |
TR200101936T2 (tr) | 2001-12-21 |
HUP0104859A3 (en) | 2002-11-28 |
ATE262517T1 (de) | 2004-04-15 |
KR20010102968A (ko) | 2001-11-17 |
BR0008589A (pt) | 2002-01-29 |
EP1140895B1 (en) | 2004-03-24 |
DE60009260D1 (de) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20190326A1 (es) | Isoquinolin-3-il-carboxamidas y preparacion y uso de las mismas | |
PE20060570A1 (es) | Compuestos de quinazolina e isoquinolina piperidilo sustituidos como inhibidores de fosfodiesterasa pde-10 | |
AR106755A2 (es) | Inhibidores pirrólicos de la proteína quinasa erk, síntesis e intermediarios de los mismos | |
PE20190656A1 (es) | Compuestos de tiazolo-piridina sustituida como inhibidores de malt1 | |
AR111813A2 (es) | Compuestos y composiciones para el control de nematodos | |
PE20080524A1 (es) | DERIVADOS DE 1H-IMIDAZO[4,5-b]PIRAZIN Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN | |
PE20040450A1 (es) | Heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida como inhibidores de metaloproteinasa | |
EA200500017A1 (ru) | Новые соединения | |
EA200970207A1 (ru) | Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов | |
ECSP088149A (es) | 3-acilaminobenzanilidas insecticidas | |
UY29479A1 (es) | Inhibidores de adn-pk | |
EA200401157A1 (ru) | N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv | |
ATE396993T1 (de) | Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität | |
AR047531A1 (es) | Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa | |
EA200600594A1 (ru) | Новые гетероциклические соединения - ингибиторы hsp90 и способы их получения | |
ATE369370T1 (de) | Substituierte 2h-(1,2,4)triazolo(4,3-a)pyrazine als gsk-3-inhibitoren | |
BRPI0711310B8 (pt) | composto inibidor de p38 map cinase, composição farmacêutica compreendendo o mesmo e uso do mesmo | |
EA201070966A1 (ru) | Фолаты, композиции и применение указанных композиций | |
CY1107196T1 (el) | Υποκατεστημενα παραγωγα 2,4-διϋδρο-πυρρολο (3,4-β) -κινολιν-9-ονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
AR022213A1 (es) | Compuestos ciclicos utiles como inhibidores de metaloproteinas, proceso para prepararlos; composiciones formuladas con dichos compuestos; proceso parapreparar dichas composiciones; uso de dichos compuestos | |
AR097325A1 (es) | Pirroles anillados | |
PE20010685A1 (es) | Composicion que comprende un polipeptido antagonista del receptor de interleuquina 1 y una diarilsulfonilurea como inhibidor del procesamiento y la liberacion de il-1 | |
WO2006020358A3 (en) | Novel biphenyl compounds and their use | |
ATE484508T1 (de) | Furylverbindungen | |
GT200300187A (es) | Compuestos antiinflamatorios de di y trifluoro-triazolo-piridinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |